Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development

dc.contributor.authorRolan, Paul Edwarden
dc.contributor.authorAtkinson, Arthur J.en
dc.contributor.authorLesko, L. J.en
dc.contributor.schoolSchool of Medical Sciences : Pharmacologyen
dc.contributor.schoolSchool of Medical Sciences : Pharmacologyen
dc.date.issued2003en
dc.description© Mosbyen
dc.description.statementofresponsibilityPaul Rolan, Arthur J. Atkinson Jr, Lawrence J. Leskoen
dc.identifier.citationClinical Pharmacology & Therapeutics, 2003; 73 (4):284-291en
dc.identifier.doi10.1016/S0009-9236(02)17625-9en
dc.identifier.issn0009-9236en
dc.identifier.urihttp://hdl.handle.net/2440/33966
dc.language.isoenen
dc.publisherMosbyen
dc.titleUse of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Developmenten
dc.typeJournal articleen

Files